Results 141 to 150 of about 1,634 (161)

Nieuw geneesmiddel: nirsevimab

Ge-Bu, 2023
openaire   +1 more source

Nirsevimab: The Hidden Costs

Hospital Pediatrics
Samantha, Neumann, Brian, Alverson
openaire   +2 more sources

Nirsevimab

Reactions Weekly
openaire   +2 more sources

Nirsevimab for RSV Prophylaxis in Healthy Infants

AAP Grand Rounds, 2022
openaire   +1 more source

Nirsevimab for Prevention of RSV Hospitalizations in Infants

New England Journal of Medicine
Saul N, Faust, Simon B, Drysdale, Natalya C, Vassilouthis   +2 more
openaire   +3 more sources

Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of Respiratory Syncytial Virus disease among infants in Canada: a simulation study

The Lancet Regional Health Americas, 2023
Alison Galvani, Joanne M Langley, Seyed Moghadas   +2 more
exaly  

Disparities in the Availability and Acceptance of Nirsevimab in Massachusetts

Pediatrics
Claire, Abraham, Jon, Hatoun, Emily Trudell, Correa, Naveed, Rabbani, Louis, Vernacchio   +4 more
openaire   +2 more sources

Nirsevimab—a breakthrough in respiratory syncytial virus bronchiolitis

The Lancet Child & Adolescent Health
Assad, Zein, Papenburg, Jesse, Ouldali, Naïm   +2 more
openaire   +3 more sources

Effectiveness of nirsevimab in preventing RSV-hospitalisation among young children in Western Australia 2024

Journal of Infection
Ushma Wadia, Catherine Pienaar, Lana Bell   +2 more
exaly  

Factors Associated With Nirsevimab Uptake in Healthy Newborns

Hospital Pediatrics
Elena, Aragona, Veronika, Shabanova, Jaspreet, Loyal   +2 more
openaire   +2 more sources